| V Marcel |
TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li-Fraumeni syndrome: impact on age at first diagnosis. |
2009 |
7 |
- |
| Fenghua Zhang |
Significance of MDM2 and P14 ARF polymorphisms in susceptibility to differentiated thyroid carcinoma. |
2013 |
1 |
10.1016/j.surg.2012.11.009 |
| Tatsuya Toyama |
Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients |
2007 |
9 |
10.1186/bcr1682 |
| Xiaoyong Wang |
Interaction of Helicobacter pylori with genetic variants in the MDM2 promoter, is associated with gastric cancer susceptibility in Chinese patients. |
2009 |
3 |
HEL712 [pii]\n10.1111/j.1523-5378.2009.00712.x |
| Lichun Wang |
Effects of murine double minute 2 polymorphisms on the risk and survival of osteosarcoma: a systemic review and meta-analysis. |
2013 |
1 |
10.1007/s13277-013-1227-8 |
| Geoffrey Liu |
Genetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk. |
2008 |
2 |
10.1002/ijc.23178 |
| Takeshi Tomoda |
Genetic risk of hepatocellular carcinoma in patients with hepatitis C virus: a case control study. |
2012 |
1 |
- |
| Piotr Piotrowski |
Murine double minute clone 2 309T/G and 285G/C promoter single nucleotide polymorphism as a risk factor for breast cancer: a Polish experience |
2012 |
1 |
10.5301/JBM.2012.9140 |
| Hiroshi Hirata |
MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma. |
2007 |
15 |
10.1158/1078-0432.CCR-07-0609 |
| Marie-Eve Lalonde |
Identification of functional DNA variants in the constitutive promoter region of MDM2 |
2012 |
2 |
10.1186/1479-7364-6-15 |
| Chih-Chieh Wu |
Joint effects of germ-line TP53 mutation, MDM2 SNP309, and gender on cancer risk in family studies of Li-Fraumeni syndrome. |
2011 |
3 |
- |
| Chih-Chieh Wu |
Joint effects of germ-line TP53 mutation, MDM2 SNP309, and gender on cancer risk in family studies of Li-Fraumeni syndrome. |
2011 |
6 |
10.1007/s00439-011-0957-1 |
| Yong Ma |
<italic>MDM2</italic> SNP309 rs2279744 Polymorphism and Gastric Cancer Risk: A Meta-Analysis |
2013 |
1 |
10.1371/journal.pone.0056918 |
| Xingming Chen |
Human papillomavirus seropositivity synergizes with MDM2 variants to increase the risk of oral squamous cell carcinoma. |
2010 |
13 |
10.1158/0008-5472.CAN-09-4733 |
| Jing Dong |
MDM2 SNP309 contributes to non-small cell lung cancer survival in Chinese. |
2011 |
7 |
10.1002/mc.20727 |
| Lei Jin |
Genetic Variation in MDM2 and p14ARF and Susceptibility to Salivary Gland Carcinoma |
2012 |
5 |
10.1371/journal.pone.0049361 |
| Li-Hong Wang |
MDM2 rs2279744 polymorphism and endometrial cancer: a meta-analysis. |
2013 |
1 |
10.1007/s13277-013-1413-8 |
| Xingming Chen |
Human papillomavirus seropositivity synergizes with MDM2 variants to increase the risk of oral squamous cell carcinoma. |
2010 |
9 |
- |
| Yong Ma |
MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis. |
2013 |
3 |
10.1371/journal.pone.0056918 |
| Geoffrey Liu |
Genetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk. |
2008 |
1 |
- |
| Andreas Woelfelschneider |
A distinct ERCC1 haplotype is associated with mRNA expression levels in prostate cancer patients. |
2008 |
3 |
DOI 10.1093/carcin/bgn067 |
| Hikmet Akkiz |
MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population. |
2010 |
2 |
10.1016/j.canep.2010.04.008 |
| Kirstin Mittelstrass |
Early onset lung cancer, cigarette smoking and the SNP309 of the murine double minute-2 (MDM2) gene |
2008 |
4 |
10.1186/1471-2407-8-113 |
| Faith Pangilinan |
Construction of a high resolution linkage disequilibrium map to evaluate common genetic variation in TP53 and neural tube defect risk in an Irish population. |
2008 |
6 |
10.1002/ajmg.a.32504 |
| Jing Dong |
MDM2 SNP309 contributes to non-small cell lung cancer survival in Chinese. |
2011 |
4 |
10.1002/mc.20727 |
| Karin Leander |
NAMPT (visfatin) and AKT1 genetic variants associate with myocardial infarction. |
2012 |
2 |
10.1016/j.cca.2012.01.002 |
| Stian Knappskog |
<italic>MDM2</italic> Promoter SNP344T>A (rs1196333) Status Does Not Affect Cancer Risk |
2012 |
1 |
10.1371/journal.pone.0036263 |
| Fenghua Zhang |
Significance of MDM2 and P14ARF polymorphisms in susceptibility to differentiated thyroid carcinoma |
2013 |
2 |
10.1016/j.surg.2012.11.009 |
| Maria Lina Tornesello |
MDM2 and CDKN1A gene polymorphisms and risk of Kaposi's sarcoma in African and Caucasian patients. |
2011 |
0 |
- |
| Yong Ma |
MDM2 SNP309 rs2279744 Polymorphism and Gastric Cancer Risk: A Meta-Analysis |
2013 |
1 |
10.1371/journal.pone.0056918 |
| Howard Dean Hosgood |
Etiology of lung cancer and environmental risk factors in Xuanwei, China. |
2008 |
2 |
|
| Hikmet Akkiz |
MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population |
2010 |
3 |
10.1016/j.canep.2010.04.008 |
| Jan Sommerfelt-Pettersen |
MDM2 Promoter SNP344T>A (rs1196333) Status Does Not Affect Cancer Risk |
2012 |
2 |
10.1371/journal.pone.0036263 |
| D J Renouf |
Association of the MDM2 T309G polymorphism and gastroesophageal reflux disease (GERD) with overall survival (OS) in esophageal adenocarcinoma (EAC) |
2011 |
3 |
- |
| Xuemei Zhang |
Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer. |
2006 |
8 |
- |
| Kirstin Mittelstrass |
Early onset lung cancer, cigarette smoking and the SNP309 of the murine double minute-2 (MDM2) gene. |
2008 |
5 |
10.1186/1471-2407-8-113 |
| Laurent Castéra |
MDM2 as a modifier gene in retinoblastoma. |
2010 |
8 |
- |
| Stian Knappskog |
MDM2 promoter SNP344T>A (rs1196333) status does not affect cancer risk |
2012 |
3 |
10.1371/journal.pone.0036263 |
| Hiroshi Hirata |
MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma. |
2007 |
12 |
- |
| Laurent Castéra |
MDM2 as a modifier gene in retinoblastoma. |
2010 |
9 |
10.1016/j.yoph.2011.02.001 |
| Xiaoyong Wang |
Interaction of <i>Helicobacter pylori</i> with Genetic Variants in the MDM2 Promoter, is Associated with Gastric Cancer Susceptibility in Chinese Patients |
2009 |
1 |
10.1111/j.1523-5378.2009.00712.x |
| Hikmet Akkiz |
MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population. |
2010 |
2 |
- |
| H Uthoff |
Title page. |
2010 |
25 |
10.2165/20102801-000000000-00000 |
| Valeria Di Vuolo |
TP53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients |
2011 |
1 |
10.1186/1750-9378-6-13 |
| D J Renouf |
Association of the MDM2 T309G polymorphism and gastroesophageal reflux disease (GERD) with overall survival (OS) in esophageal adenocarcinoma (EAC) |
2011 |
2 |
|
| Yong Ma |
MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis. |
2013 |
1 |
10.1371/journal.pone.0056918 |
| Yong Ma |
MDM2 SNP309 rs2279744 Polymorphism and Gastric Cancer Risk: A Meta-Analysis |
2013 |
3 |
10.1371/journal.pone.0056918 |
| Yubin Liu |
Murine double minute 2 rs2279744 polymorphism and hepatocellular carcinoma risk in East Asians: a meta-analysis. |
2013 |
1 |
10.1007/s13277-013-1128-x |
| O M Sinilnikova |
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. |
2009 |
5 |
10.1038/sj.bjc.6605279 |
| Stian Knappskog |
MDM2 Promoter SNP344TA (rs1196333) Status Does Not Affect Cancer Risk |
2012 |
2 |
10.1371/journal.pone.0036263 |